Fibrinolysis Shutdown and Thrombosis in Severe COVID-19
Jansen N. Seheult, Anupamaa Seshadri, Matthew D. Neal
Abstract
Pittsburgh, PA Disclosure Information: Dr Neal has received research support and personal fees from Janssen Pharmaceuticals and Haemonetics. He receives research support from Instrumentation Labs and Noveome. He serves on the Scientific Advisory Board of Haima Therapeutics. Support: Dr Neal receives research support from the NIH/NIGMS and the Department of Defense (R35GM119526-05).
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)FibrinolysisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakShutdownVirologyPathologyInternal medicineDiseaseNuclear engineeringEngineeringInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Adipokines, Inflammation, and Metabolic Diseases